Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 31;18(1):2024064.
doi: 10.1080/21645515.2021.2024064. Epub 2022 Feb 7.

Knowledge and willingness to receive a COVID-19 vaccine: a survey from Anhui Province, China

Huoba Li  1 , Lulu Cheng  2 , Juan Tao  3 , Deyu Chen  4 , Chenchen Zeng  5
Affiliations

Knowledge and willingness to receive a COVID-19 vaccine: a survey from Anhui Province, China

Huoba Li et al. Hum Vaccin Immunother. .

Abstract

Objectives: Vaccinations can prevent COVID-19 and control its spread quickly and efficiently. This study aimed to investigate knowledge and willingness of geriatric care facility staff to receive a COVID-19 vaccine, and to provide a basis for the government to promote the COVID-19 vaccine and guide people to get vaccinated.

Study design: A cross-sectional study.

Methods: Data on characteristics of the participants, knowledge about the COVID-19 vaccine, and willingness to get vaccinated for COVID-19 were collected through an online survey from May 19 to June 18, 2021. Statistical analyses were conducted with ANOVA, chi-square, logistic regression.

Results: The survey illustrated that the highest score of COVID-19 vaccine knowledge was 50, the lowest 20, and the average 44.22. It also demonstrated that 91.3% of the participants had a good knowledge of COVID-19 vaccine, and that 97.3% participants were willing to receive the COVID-19 vaccine. The results showed that geriatric care facility staff had varied level of the COVID-19 vaccine knowledge depending upon their age, educational background, and other factors, and correspondingly, their willingness to receive COVID-19 vaccine was affected by their knowledge level of COVID-19 vaccine.

Conclusions: In general, the participants, the staff of geriatric care facilities in Anhui Province, had good mastery of the COVID-19 vaccine, and they were willing to get vaccinated. However, there still existed a few participants with poor knowledge, who were unwilling to get vaccinated against COVID-19. Government can guide people to accept vaccination by enhancing publicity about the effects and adverse reactions of COVID-19 vaccines.

Keywords: COVID-19 vaccine; geriatric care facility; knowledge; survey; willingness.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the authors.

References

    1. Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S.. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020. Sep 1;16(9):2204–8. doi: 10.1080/21645515.2020.1790279. - DOI - PMC - PubMed
    1. Okubo R, Yoshioka T, Nakaya T, Hanibuchi T, Okano H, Ikezawa S, Tsuno K, Murayama H, Tabuchi T.. Urbanization level and neighborhood deprivation, not COVID-19 case numbers by residence area, are associated with severe psychological distress and new-onset suicidal ideation during the COVID-19 pandemic. J Affect Disord. 2021. May 15;287:89–95. doi: 10.1016/j.jad.2021.03.028. - DOI - PMC - PubMed
    1. Ditekemena JD, Nkamba DM, Mutwadi A, Mavoko HM, Siewe Fodjo JN, Luhata C, Obimpeh M, Van Hees S, Nachega JB, Colebunders R. COVID-19 Vaccine Acceptance in the Democratic Republic of Congo: A Cross-Sectional Survey. Vaccines (Basel). 2021. Feb 14;9(2):153. doi: 10.3390/vaccines9020153. - DOI - PMC - PubMed
    1. Zhu F, Jin P, Zhu T, Wang W, Ye H, Pan H, Hou L, Li J, Wang X, Wu S, et al. Safety and immunogenicity of a recombinant adenovirus type-5-vectored COVID-19 vaccine with a homologous prime-boost regimen in healthy participants aged 6 years and above: a randomised, double-blind, placebo-controlled, phase 2b trial. Clin Infect Dis. 2021. Sep 22. doi: 10.1093/cid/ciab845. - DOI - PMC - PubMed
    1. Zhu Y, Li J, Pang Z. Recent insights for the emerging COVID-19: drug discovery, therapeutic options and vaccine development. Asian J Pharm Sci. 2021. Jan;16(1):4–23. doi: 10.1016/j.ajps.2020.06.001. - DOI - PMC - PubMed

Publication types

Substances